超強活性第九因子FIX-TripleL進行B型血友病基因治療的臨床前毒性及安全性評估(II)

Project title

超強活性第九因子FIX-TripleL進行B型血友病基因治療的臨床前毒性及安全性評估(II)

Internal ID

109-2321-B-002-057-

Principal Investigator

Start Date

November 1, 2020

End Date

September 30, 2021

Organizations

Clinical Laboratory Sciences and Medical Biotechnology

Partner Organizations

National Science and Technology Council